VisionCare Ophthalmic Technologies, Inc.
PrivateLast Round
IPO
Jan 28, 2022
Est. Valuation
$150M
Total Funding Raised
$74.2M
Company Overview
VisionCare Ophthalmic Technologies, Inc. is a medical device company that develops, manufactures, and markets implantable ophthalmic devices, including the Implantable Miniature Telescope, to improve vision for patients with end-stage age-related macular degeneration.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Patient Engagement
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VisionCare Ophthalmic Technologies, Inc. Comparables
Compare VisionCare Ophthalmic Technologies, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zyvex Labs | 82% | |
| Medicontur | 81% | |
| Science Corporation | 78% |
For institutional investors. Book with your work email.
VisionCare Ophthalmic Technologies, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Jan 28, 2022 | ||||
| VC Round | Dec 16, 2014 | ||||
| Series E Extension | Jan 22, 2012 | ||||
| Series E | Jan 10, 2011 | ||||
| Series D | Jan 7, 2005 | ||||
Series C | Nov 7, 2003 |
For institutional investors. Book with your work email.
VisionCare Ophthalmic Technologies, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Saints Capital | Series E |
| Giza Venture Capital | Series E |
| Agate Medical Investments | Series E Extension |
| Pitango Venture Capital | Series D, Series C, Series E Extension, Series E |
| ONSET Ventures | Series D, Series C, Series E |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 16, 2014
Completed a VC Round funding round.
- Jan 22, 2012
$4M round led by Agate Medical Investments.
For institutional investors. Book with your work email.
VisionCare Ophthalmic Technologies, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about VisionCare Ophthalmic Technologies, Inc.'s valuation, stock price, and market status.
Is VisionCare Ophthalmic Technologies, Inc. a public or private company?
VisionCare Ophthalmic Technologies, Inc. is a private company.
What is the current stock price of VisionCare Ophthalmic Technologies, Inc.?
VisionCare Ophthalmic Technologies, Inc. is a private company, so its shares have no public market price. Caplight tracks VisionCare Ophthalmic Technologies, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is VisionCare Ophthalmic Technologies, Inc. worth (valuation)?
VisionCare Ophthalmic Technologies, Inc.'s valuation is estimated at $150.0M based on funding round data.
Can I buy VisionCare Ophthalmic Technologies, Inc. stock?
VisionCare Ophthalmic Technologies, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was VisionCare Ophthalmic Technologies, Inc.'s last funding round?
VisionCare Ophthalmic Technologies, Inc.'s most recent funding round was IPO on January 28, 2022.
Who are the main investors in VisionCare Ophthalmic Technologies, Inc.?
Key investors in VisionCare Ophthalmic Technologies, Inc. include Saints Capital, Agate Medical Investments.
Will VisionCare Ophthalmic Technologies, Inc. IPO soon?
No public IPO plans have been announced for VisionCare Ophthalmic Technologies, Inc..
How can I track VisionCare Ophthalmic Technologies, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in VisionCare Ophthalmic Technologies, Inc.'s shares on secondary markets.